Molecular Medicine Reports

Molecular Medicine Reports is a monthly peer-reviewed journal published by Spandidos Publications that covers molecular medicine and related experimental fields, established in 2008, with a 2025 Journal Impact Factor of 5.0.《分子医学报告》（Molecular Medicine Reports）由（Spandidos Publications）出版，2008 年创刊，月刊，覆盖分子医学及相关实验领域，2025 年期刊影响因子为 5.0。

Scope

• The journal publishes articles devoted to molecular medicine, with special emphasis on biology, pharmacology and pathology.刊物发表分子医学方向的论文，特别侧重生物学、药理学与病理学。
• Gene therapy, genetics and microbiology are named among its core subject areas.基因治疗、遗传学与微生物学被列为其核心学科领域。
• Neurosciences and infectious diseases are also covered.神经科学与感染性疾病同样在其覆盖之内。
• Molecular cardiology and molecular surgery form two further declared areas of interest.分子心脏病学与分子外科构成另外两个明确列出的关注领域。
• In vitro and in vivo studies of experimental model systems are used to illuminate disease mechanisms and to aid diagnosis and treatment.刊物以实验模型系统的体外与体内研究阐明疾病机制，并服务于诊断与治疗。
• The journal offers rapid publication for accepted work.刊物对录用稿件提供快速出版通道。

History

• Molecular Medicine Reports was founded in 2008 by Spandidos Publications, a Greek publisher based in Athens.《分子医学报告》2008 年由总部位于雅典的希腊出版机构（Spandidos Publications）创办。
• It has been published continuously since then and appears monthly in print and online editions.刊物此后持续出版，按月发行印刷版与在线版。
• The title carries ISSN 1791-2997 and e-ISSN 1791-3004.刊物使用刊号 1791-2997 与电子刊号 1791-3004。
• Publication is supported by article charges, with a subscription or open access option chosen after acceptance.刊物通过文章费用维持出版，作者在录用后可选择订阅或开放获取路径。
• Its 2025 Journal Impact Factor is 5.0, after 3.5 in 2024, 3.423 in 2022 and 2.952 in 2021.2025 年期刊影响因子为 5.0，此前 2024 年为 3.5，2022 年为 3.423，2021 年为 2.952。
• The journal ranks in the second quartile in both oncology and medicine, research and experimental.刊物在肿瘤学以及医学研究与实验两个类别中均位列二区。
• Reported handling is rapid, with a typical review time of about six weeks.刊物公布的流程较快，典型审稿周期约六周。

Editors

• The Editor-in-Chief is Demetrios A. Spandidos, professor at the Medical School of the University of Crete in Heraklion, Greece.主编为（Demetrios A. Spandidos），希腊伊拉克利翁克里特大学医学院教授。
• Spandidos founded the publishing house that carries the journal and works on pathology, cancer and gene editing.（Spandidos）创办了出版该刊的机构，其研究方向为病理学、癌症与基因编辑。
• The editorial office is based in Athens and handles submission and correspondence centrally.刊物编辑部设于雅典，集中处理投稿与通信事务。
• A broad editorial board supports the journal's wide subject coverage across molecular medicine.编委会规模较大，支持刊物在分子医学上的广泛学科覆盖。
• Manuscripts are submitted through the publisher's website and peer reviewed before acceptance.稿件经出版方网站提交，并在录用前经过同行评审。